Product Information
METHYLERGONOVINE 0.2 MG TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $4.3506 per EA under NDC 00093365522. Its NADAC has been published 312 times since May 1, 2019.
FDA first approved this application on Mar 20, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
.2 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093365522
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
METHYLERGONOVINE MALEATEApproval Type
Generic (ANDA)
FDA Application
ANDA211455FDA Approved
3/20/2019
TE Code
AB
On Market Since
3/26/2019
Pharmacological Classes
Price Statistics
The NADAC for METHYLERGONOVINE 0.2 MG TABLET has been published 312 times since May 1, 2019, and over the history we have for it it has declined 89.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $4.3506 per EA |
|---|---|
| All-time high | $41.7108 (Jul 10, 2019) |
| All-time low | $4.3506 (Aug 19, 2026) |
| 52-week high | $5.9732 |
| 52-week low | $4.3506 |
| Median price | $11.9618 |
| Average price | $13.8648 |
| Largest weekly change | -51.3% (Apr 21, 2021) |
| Weeks tracked | 312 |
| Tracking since | May 1, 2019 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of METHYLERGONOVINE 0.2 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for METHYLERGONOVINE 0.2 MG TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $4.3506 per EA (NDC 00093365522), effective Aug 19, 2026.
How has the price of METHYLERGONOVINE 0.2 MG TABLET changed over time?
Over the history we have for it, the NADAC for METHYLERGONOVINE 0.2 MG TABLET has declined 89.6%. It has been tracked across 312 weekly CMS publications since May 1, 2019.
What are the highest and lowest recorded NADAC prices for METHYLERGONOVINE 0.2 MG TABLET?
Since May 1, 2019, the NADAC for METHYLERGONOVINE 0.2 MG TABLET has ranged from a low of $4.3506 (Aug 19, 2026) to a high of $41.7108 (Jul 10, 2019), with a median of $11.9618 per EA.
Are there cheaper alternatives to METHYLERGONOVINE 0.2 MG TABLET?
5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as METHYLERGONOVINE 0.2 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures METHYLERGONOVINE 0.2 MG TABLET?
METHYLERGONOVINE 0.2 MG TABLET (NDC 00093365522) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.